AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $166,000 | -50.9% | 471 | 0.0% | 0.00% | – |
| Q1 2022 | $338,000 | -68.2% | 471 | 0.0% | 0.00% | – |
| Q4 2021 | $1,064,000 | -21.5% | 471 | 0.0% | 0.00% | – |
| Q3 2021 | $1,356,000 | -13.5% | 471 | 0.0% | 0.00% | – |
| Q2 2021 | $1,568,000 | -1.6% | 471 | 0.0% | 0.00% | – |
| Q1 2021 | $1,594,000 | +20.8% | 471 | 0.0% | 0.00% | – |
| Q4 2020 | $1,319,000 | +11.6% | 471 | 0.0% | 0.00% | – |
| Q3 2020 | $1,182,000 | -81.5% | 471 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $6,396,000 | +79.2% | 471 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $3,570,000 | +1.4% | 471 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,522,000 | +90.8% | 471 | 0.0% | 0.00% | – |
| Q3 2019 | $1,846,000 | -19.0% | 471 | 0.0% | 0.00% | – |
| Q2 2019 | $2,279,000 | -40.9% | 471 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $3,856,000 | +48.1% | 471 | 0.0% | 0.00% | – |
| Q4 2018 | $2,604,000 | – | 471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |